| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225852 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
The overall survival rate did not reach the projected goal; however, rates of esophagitis were lower, and local control higher, than projected. This treatment strategy is now one of three arms of a prospective trial of chemoradiation for LSCLC (Radiation Therapy Oncology Group 0538/Cancer and Leukemia Group B 30610).
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ritsuko MD, Rebecca BS, David S. MD, Gregory M.M. MD, Jeffrey D. MD, Bonnie S. MD, Corey J. MD, William T. MD, Walter J. MD, Hak MD,